[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "UK surge continues", "description": "Most common symptoms, Runny nose, 82% Fatigue, 70% Headache, 69%\n\nSore throat, 69%\n\nSneezing, 68%\n\nPersistent cough, 53%\n\nHoarse, 46%\n\nChills or shivers, 36%\n\nJoint pains, 33%\n\nFever, 32%\n\nDizzy, 30%\n\nBrain fog, 27%\n\nSore eyes, 25%\n\nAltered smell, 24%\n\nMuscle pains, 23%\n\nLower back pain, 23%\n\nSwollen glands, 21%\n\nSkipped meals, 18%\n\nEar ringing, 17%\n\nCovid more common than colds\n\nEven if testing negative\nUK\n\nhttps://covid.joinzoe.com/data\n\nONS\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights\n\n\nPercentage of the community population that had COVID-19 up to 19 March 2022\n\n6.39% in England (1 in 16 people)\n\n6.35% in Wales (1 in 16 people) \n\n5.92% in Northern Ireland \n(1 in 17 people) \n\n9.00% in Scotland (1 in 11 people)\n\nAntibodies\n\n99.0% in England\n\n98.9% in Wales \n\n98.8% in Northern Ireland \n\n99.0% in Scotland\n\nUnvaccinated pupils were more likely to become infected with COVID-19 in the Autumn 2021 term\n\nCompared with unvaccinated pupils\n\nThose aged 12 to 15 years,\nwho had received one vaccine dose more than 14 days ago: \n\nwere 23% less likely to report a positive test\n\n(second half of the Autumn 2021 term 4th  November to 17th  December 2021)\n\nUK official data\n\nhttps://coronavirus.data.gov.uk/", "link": "https://www.youtube.com/watch?v=UFWICK4ePg0", "date_published": "2022-03-29 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "US and China and BA 2", "description": "The World Health Organization decides BA.2 is more transmissible than BA.1\n\nhttps://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---8-march-2022\n\nhttps://www.nytimes.com/interactive/2022/03/28/opinion/coronavirus-mutation-future.html\n\nWeekly epidemiological update on COVID-19\n\nBA.2 is main global driver\n\nFeb. 16th to March 17th \n\nBA.2 86% of global reports\n\nBA.1 and BA.1.1, together 13%\n\nBA.2 is more transmissible than BA.1\n\nNot been shown to cause more severe illness\n\nDr. Maria Van Kerkhove\n\nOur vaccines remain incredibly effective at preventing severe disease and death, including against both of the sublineages of BA.1 and BA.2\n\nDeltacron\n\nShanghai\n\nhttps://www.theguardian.com/world/2022/mar/28/shanghai-to-lock-down-millions-for-mass-testing-as-chinas-covid-cases-surge\n\nPhased lockdown, 25 million people\n\nOmicron wave \n\nEastern side, under lockdown, Monday to Friday\n\nMass testing\n\nCases, 3,450 asymptomatic cases\n\n(50 symptomatic cases)\n\nOther citywide lockdowns\n\nVaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong\n\nhttps://www.medrxiv.org/content/10.1101/2022.03.22.22272769v1\n\nThree doses of either vaccine offered very high levels of protection against severe outcomes (VE: 98.1%)\n\nThird doses of either BNT162b2 or CoronaVac provide substantial additional protection against severe COVID-19 and should be prioritized, \n\nparticularly in older adults who received CoronaVac primary schedules.\n\nUS\n\nDr. Rochelle Walensky, BA.2, third of new cases\n\nPaxlovid \n\nUS, cases\n\nhttps://covid.cdc.gov/covid-data-tracker/#datatracker-home\n \n\nUS deaths\n\n \n\n\nUS, hospital patients\n\n \n\n \n\nhttps://covid19.healthdata.org/united-states-of-america?view=cumulative-deaths&tab=trend\n\nA second booster for anyone 50 and older is expected soon (FDA, CDC)\n\nFour months after thirds shot", "link": "https://www.youtube.com/watch?v=YoDvuu9oOzg", "date_published": "2022-03-28 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]